Free Trial
→ [Action Required] Claim Your FREE IRS Loophole Guide (From Colonial Metals) (Ad) Buy IOVA Stock  Free IOVA Stock Alerts

Iovance Biotherapeutics (IOVA) SEC Filings & 10K Form

Iovance Biotherapeutics logo
$3.06 -0.02 (-0.49%)
Closing price 03:59 PM Eastern
Extended Trading
$3.08 +0.02 (+0.65%)
As of 05:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Iovance Biotherapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
03/18/2025
7:30 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:05 PM		Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:05 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:06 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:06 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:06 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:32 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:32 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:33 PM		Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:30 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:31 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:15 PM		Iovance Biotherapeutics (Issuer)
Kirby Daniel Gordon (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/12/2025
4:17 PM		Iovance Biotherapeutics (Issuer)
Kirby Daniel Gordon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:22 AM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2025
4:59 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
5:00 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
5:01 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
4:15 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
4:16 PM		Iovance Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/02/2024
4:25 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/21/2024
4:15 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:50 PM		Iovance Biotherapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
11/12/2024
6:11 PM		Iovance Biotherapeutics (Subject)
Maynard Ryan D (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
8:03 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
4:15 PM		Iovance Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2024
7:38 AM		Iovance Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/16/2024
5:30 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
5:32 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
5:33 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:52 PM		Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:53 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:54 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:56 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
4:16 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
4:10 PM		Iovance Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2024
7:00 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
7:01 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
7:01 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:30 AM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
5:00 PM		Dukes Iain D. (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:00 PM		Iovance Biotherapeutics (Issuer)
Maynard Ryan D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s treachery (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
06/13/2024
5:01 PM		Iovance Biotherapeutics (Issuer)
WEISER MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:02 PM		Iovance Biotherapeutics (Issuer)
YARNO WENDY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:03 PM		Countouriotis Athena (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:15 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
7:07 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:04 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:05 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
7:01 AM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2024
4:15 PM		Iovance Biotherapeutics (Filer)
Form DEFA14A
05/01/2024
4:05 PM		Iovance Biotherapeutics (Filer)
Form ARS
04/29/2024
4:06 PM		Iovance Biotherapeutics (Filer)
Form DEF 14A
04/29/2024
4:07 PM		Iovance Biotherapeutics (Filer)
Form DEFA14A
04/17/2024
6:07 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
6:07 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
6:08 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:IOVA) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Elon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...
InvestorPlace | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored